BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37592363)

  • 1. Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.
    Rodwin RL; DelRocco NJ; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Ma X; Angiolillo AL; Ness KK; Kairalla JA; Kadan-Lottick NS
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30634. PubMed ID: 37592363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
    Rodwin RL; Kairalla JA; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Angiolillo AL; Ness KK; Kadan-Lottick NS
    J Natl Cancer Inst; 2022 Aug; 114(8):1167-1175. PubMed ID: 35552709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
    Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
    J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.
    Gilchrist LS; Marais L; Tanner L
    Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia.
    Wright MJ; Twose DM; Gorter JW
    Gait Posture; 2017 Oct; 58():139-145. PubMed ID: 28779719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.
    Lieber S; Blankenburg M; Apel K; Hirschfeld G; Hernáiz Driever P; Reindl T
    Eur J Paediatr Neurol; 2018 May; 22(3):457-469. PubMed ID: 29396168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced Peripheral Neuropathy Among Paediatric Oncology Patients.
    Purser MJ; Johnston DL; McMillan HJ
    Can J Neurol Sci; 2014 Jul; 41(4):442-7. PubMed ID: 24878467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.
    Ramchandren S; Leonard M; Mody RJ; Donohue JE; Moyer J; Hutchinson R; Gurney JG
    J Peripher Nerv Syst; 2009 Sep; 14(3):184-9. PubMed ID: 19909482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Pediatric Chemotherapy-Induced Peripheral Neuropathy Using a New Patient-Reported Outcome Measure: The P-CIN.
    Smith EML; Kuisell C; Kanzawa-Lee G; Bridges CM; Cho Y; Swets J; Renbarger JL; Gilchrist LS
    J Pediatr Oncol Nurs; 2021; 38(2):131-141. PubMed ID: 33331218
    [No Abstract]   [Full Text] [Related]  

  • 16. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
    Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
    BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
    Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
    J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
    Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
    Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
    Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.